Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 181 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location NCT ID

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

Prostate Cancer Phase2, Phase3 Australia
Brazil
China
Hong Kong
Israel
Japan
Malaysia
Singapore
South Korea
Switzerland
Taiwan
United States
View all

Kesimpta (Ofatumumab) in Greek Multiple Sclerosis Patients - an Observational Study

Relapsing Multiple Sclerosis (RMS) Greece

Entresto Tablets and Granules for Pediatric Specified Drug-use Survey (Pediatric Chronic Heart Failure)

Pediatric Chronic Heart Failure Japan

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

Familial Hypercholesterolemia - Heterozygous Phase3 Argentina
Austria
Belgium
Brazil
China
Czechia
France
Germany
Greece
Hong Kong
Hungary
Israel
Italy
Malaysia
Netherlands
Poland
Portugal
South Africa
Spain
Taiwan
Turkey (Türkiye)
United Kingdom
United States
View all

ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS

Relapsing Remitting Multiple Sclerosis (RRMS) Phase4 Canada

A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study

Metastatic Castration-Resistant Prostate Cancer Phase1 Germany
Netherlands
Spain
Switzerland
United Kingdom
United States
View all

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

Healthy Volunteers, Pulmonary Arterial Hypertension Phase1, Phase2 Argentina
Australia
Belgium
Brazil
Czechia
France
Germany
Greece
Italy
Latvia
Mexico
Poland
Portugal
Romania
Serbia
Spain
United Kingdom
United States
View all

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

Sickle Cell Disease Phase3 Brazil
Colombia
Kenya
Uganda
United States
View all

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Spinal Muscular Atrophy (SMA) Greece
Ireland
Israel
Poland
Portugal
Romania
Russia
South Korea
Taiwan
United States
View all

A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma

Asthma Phase3 Argentina
Brazil
Bulgaria
Colombia
Greece
Guatemala
Hungary
Italy
Mexico
Panama
Portugal
Romania
South Africa
Spain
Vietnam
View all